All News

2069 articles, sorted by publication time.

Biopharma · global

Human Trial of Shigella Vaccine Shows Signal of Protection, Offering a Potential New Defense Against Diarrheal Disease

A clinical trial claims a candidate Shigella vaccine achieved 89% protection, providing an important signal in an area of intestinal infection that has long lacked a broadly usable vaccine; however, public information remains thin, and whether the results can translate into real-world vaccination will depend on the full trial design, safety, and population data.